- Home
- MUJ vs CRMD Comparison
MUJ vs CRMD Comparison
Compare MUJ & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MUJ
- CRMD
- Stock Information
- Founded
- MUJ 1998
- CRMD 2006
- Country
- MUJ United States
- CRMD United States
- Employees
- MUJ N/A
- CRMD N/A
- Industry
- MUJ Investment Bankers/Brokers/Service
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- MUJ Finance
- CRMD Health Care
- Exchange
- MUJ Nasdaq
- CRMD Nasdaq
- Market Cap
- MUJ 619.6M
- CRMD 871.9M
- IPO Year
- MUJ N/A
- CRMD 2010
- Fundamental
- Price
- MUJ $11.62
- CRMD $11.27
- Analyst Decision
- MUJ
- CRMD Strong Buy
- Analyst Count
- MUJ 0
- CRMD 8
- Target Price
- MUJ N/A
- CRMD $17.75
- AVG Volume (30 Days)
- MUJ 108.0K
- CRMD 2.4M
- Earning Date
- MUJ 01-01-0001
- CRMD 11-10-2025
- Dividend Yield
- MUJ 4.36%
- CRMD N/A
- EPS Growth
- MUJ N/A
- CRMD N/A
- EPS
- MUJ N/A
- CRMD 0.79
- Revenue
- MUJ N/A
- CRMD $121,484,498.00
- Revenue This Year
- MUJ N/A
- CRMD $480.51
- Revenue Next Year
- MUJ N/A
- CRMD $59.81
- P/E Ratio
- MUJ N/A
- CRMD $14.11
- Revenue Growth
- MUJ N/A
- CRMD 14970.29
- 52 Week Low
- MUJ $9.74
- CRMD $5.60
- 52 Week High
- MUJ $11.70
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- MUJ 59.72
- CRMD 49.41
- Support Level
- MUJ $11.50
- CRMD $10.97
- Resistance Level
- MUJ $11.62
- CRMD $11.57
- Average True Range (ATR)
- MUJ 0.08
- CRMD 0.52
- MACD
- MUJ -0.03
- CRMD 0.11
- Stochastic Oscillator
- MUJ 54.76
- CRMD 51.98
About MUJ Blackrock MuniHoldings New Jersey Quality Fund Inc.
BlackRock MuniHoldings New Jersey Quality Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide shareholders with current income exempt from U.S. federal income tax and New Jersey personal income taxes. The fund mainly invests in long-term, investment-grade municipal obligations exempt from U.S federal income taxes (except that the interest may be subject to the U.S. federal alternative minimum tax) and New Jersey personal income taxes, with remaining maturities of one year or more at the time of investment. The rest of its managed assets can be invested in securities that are rated below investment grade (or similar instruments), or invested directly in securities or synthetically through the use of derivatives.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.